CONCORD BIOTECH LTD (India) holds 23 active US FDA Type II Drug Master Files and 1 inactive, has DMF or CEP filings on record for 21 active ingredients and is linked to 2 FDA-registered manufacturing sites. 2 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “CONCORD BIOTECH LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/concord-biotech-ltd

Overview

CONCORD BIOTECH LTD is an active pharmaceutical ingredient (API) supplier with 22 active FDA Type II Drug Master Files, covering CYCLOSPORINE USP; DACTINOMYCIN USP; EVEROLIMUS USP (WITH 2% BHT); LOVASTATIN USP; MIDOSTAURIN; MITOMYCIN USP.

Core services & business areas

API Manufacturing

Active ingredients with DMF or CEP filings

Substances for which CONCORD BIOTECH LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

CONCORD BIOTECH LTD holds 23 active (24 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • FIDAXOMICIN (CRYSTALLINE)Active2026-08-10
  • NYSTATIN USPActive2025-04-19
  • VOCLOSPORINActive2024-10-16
  • STAUROSPORINE TECHNICALActive2020-12-11
  • MIDOSTAURINActive2020-10-27
  • TACROLIMUS USP (PROCESS II)Active2020-01-16
  • DACTINOMYCIN USPActive2019-11-06
  • MITOMYCIN USPActive2019-04-20
  • PIMECROLIMUS USPActive2015-09-15
  • MYCOPHENOLATE MOFETIL USP (BY AZEOTROPIC DISTILLATION)Active2015-09-04
  • MUPIROCIN CALCIUM USPActive2015-01-07
  • MUPIROCIN USPActive2014-10-08
  • ROMIDEPSINActive2013-11-01
  • EVEROLIMUS USP (WITH 2% BHT)Active2013-06-14
  • TEMSIROLIMUSActive2011-05-28
  • SIROLIMUSActive2011-02-24
  • CYCLOSPORINE USPActive2010-07-08
  • VANCOMYCIN HYDROCHLORIDE USPActive2009-02-10
  • MYCOPHENOLATE SODIUM USPActive2008-08-21
  • PRAVASTATIN SODIUM USPActive2007-08-16
  • MYCOPHENOLATE MOFETIL USPActive2006-03-07
  • TACROLIMUS USPActive2005-10-24
  • LOVASTATIN USPActive2004-05-17
  • SIMVASTATIN USPInactive2005-12-13

Registered manufacturing sites (2)

Physical sites registered with the US FDA and resolved to CONCORD BIOTECH LTD, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

2 FDA enforcement records linked to this company.

  • 4832023-03-17

    Procedures not in writing, fully followed

  • 4832023-03-17

    Investigations of discrepancies, failures

For suppliers

Is this CONCORD BIOTECH LTD?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.